Serum soluble CD44 in pediatric patients with acute leukemia

Journal of Pediatric Hematology/Oncology

Volumn 21, Issue 5, 1999, Pages 384-388

  Takeuchi, Motohiro ^a   Tanizawa, Akihiko ^a   Fukumoto, Yukiko ^a   Kikawa, Yoshiharu ^a   Mayumi, Mitsufumi ^a  

^a University of Fukui   (Japan)

Author keywords

Acute leukemia; Soluble CD44

Indexed keywords

HERMES ANTIGEN; TUMOR MARKER;

ACUTE LEUKEMIA; ANTIGEN DETECTION; ARTICLE; BLOOD LEVEL; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; HUMAN; METASTASIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD; ANTIGENS, CD44; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; CYTARABINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; METHOTREXATE; PREDNISOLONE; REFERENCE VALUES; REMISSION INDUCTION; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE;

EID: 0033496771     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199909000-00009     Document Type: Article

References (29)

1. Screaton GR, Bell MV, Jackson DG, et al. Genomic structure of DNA encoding the lymphocyte coding receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89:12160-4.
2. Günthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
3. Wielanga VJM, Heider KH, Offerhaus GJA. et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993;53:4754-6.
4. Kaufmann M, Heider KH, Sinn HP, et al. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995;345:615-9.
5. Stauder R, Eisterer W, Thaler J, et al. CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor. Blood 1995;85:2885-99.
6. Ristamäki R, Joensuu H, Söderström KO, et al. CD44v6 expression in non-Hodgkin's lymphoma. An association with low histological grade and poor prognosis. J Pathol 1995;176:259-67.
7. Legras S, Gunthert U, Stauder R, et al. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood 1998;91:3401-13.
8. Bazil V, Horejsi V, Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody stimulating the effect of a natural receptor ligand. J Immunol 1992;149:747-53.
9. Yang H, Binns RM. Isolation and characterization of the soluble and membrane-bound porcine CD44 molecules. Immunology 1993;78:547-54.
10. Guo YJ, Liu G, Wang X, et al. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res 1994;54:422-6.
11. Martin S, Jansen F, Bokelmann J, et al. Soluble CD44 splice variants in metastasizing human breast cancer. Int J Cancer 1997;74: 443-5.
12. Ristamäki R, Joensuu H, Salmi M, et al. Serum CD44 in malignant lymphoma: An association with treatment response. Blood 1994; 84:238-43.
13. De Rossi G, Marroni P, Paganuzzi M, et al. Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemia. Leukemia 1997;11:134-41.
14. Ristamäki R, Joensuu H, Lappalainen K, et al. Elevated serum CD44 level is associated with unfavorable outcome in non-Hodgkin's lymphoma. Blood 1997;90:4039-45.
15. De Rossi G, Tenca C, Zarcone D, et al. Variant isoforms of the lymphocyte homing receptor, CD44, in B-cell lymphocytic leukemia. Blood 1994;84:459a.
16. Ghaffari S, Dougherty GJ, Lansdorp PM, et al. Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood 1995;86:2976-85.
17. Csanaky G, Matutes E, Vass JA, et al. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias. Leukemia 1997;11:408-15.
18. Rutella Sica S, Etuk B, et al. Flow cytometric detection of CD44 (H-CAM) in hairy cell leukemia. Leukemia Lymphoma 1996;21: 497-500.
19. Escribano L, Orfao A, Villarrubia J, et al. Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 1997;30:98-102.
20. Ghaffari S, Dougherty GJ, Eaves AC, et al. Altered patterns of CD44 epitope expression in human chronic and acute myeloid leukemia. Leukemia 1996;10:1773-81.
21. Kortlepel K, Bendall LJ, Gottlieb DJ, et al. Human acute myeloid leukaemia cells express adhesion proteins and bind to bone marrow fibroblast monolayers and extracellular matrix proteins. Leukemia 1993;7:1174-9.
22. Ristamäki R, Joensuu H, Grön-Virta K, et al. Origin and function of circulating CD44 in non-Hodgkin's lymphoma. J Immunol 1997;158:3000-8.
23. Soukka T, Salmi M, Joensuu H, et al. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Res 1997;57:2281-9.
24. Hudson DL, Speight PM, Watt FM. Altered expression of CD44 isoforms in squamous cell carcinomas and cell-lines derived from them. Int J Cancer 1996;66:457-63.
25. Seelentag WK, Günthert U, Saremaslani P, et al. CD44 standard and variant isoforms expression in human epidermal skin tumors is not correlated with tumor progrerssiveness but down-regulated during proliferation and tumor de-differentiation. Int J Cancer 1996;69:218-24.
26. Spafford MF, Koeppe J, Pan Z, et al: Correlation of tumor markers p-53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1996;122:627-32.
27. Hong RL, Pu YS, Hsieh TS, et al. Expression of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma. J Urol 1995;153:2025-8.
28. Ross JS, Del Rosario AD, Bui HX, et al. Expression of CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma. Mod Pathol 1996;9:854-60.
29. Sugino T, Gorham H, Yoshida K, et al. Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Pathol 1996; 149:873-82.